IPM-514

N/A

Report date: 2026/05/12 15:11:26

Base Information

Drug NameIPM-514
Drug Alias NameIPM514IPM-514
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > RNA vaccine > mRNA vaccineVaccines > Application > Therapeutic vaccineCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsEsophageal Squamous Cell Carcinoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Zhenzhi Medical Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Zhenzhi Medical Technology Co LtdPeking University
Inactive CompaniesN/A
Active IndicationsEsophageal Squamous Cell Carcinoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A